Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test October 9, 2017 5 Top Biotech Stocks That Look Vulnerable in 2018 January 8, 2018 Top 10 R&D Scientist Skills in Demand April 26, 2017